NDC 57826-426

Haemonetics Anticoagulant Citrate Dextrose Solution

Anhydrous Citric Acid, Trisodium Citrate Dihydrate, Dextrose Monohydrate

Haemonetics Anticoagulant Citrate Dextrose Solution is a Extracorporeal Solution in the Human Prescription Drug category. It is labeled and distributed by Haemonetics Corporation. The primary component is Anhydrous Citric Acid; Trisodium Citrate Dihydrate; Dextrose Monohydrate.

Product ID57826-426_6ad8c143-8921-7ce1-e053-2a91aa0a6d78
NDC57826-426
Product TypeHuman Prescription Drug
Proprietary NameHaemonetics Anticoagulant Citrate Dextrose Solution
Generic NameAnhydrous Citric Acid, Trisodium Citrate Dihydrate, Dextrose Monohydrate
Dosage FormSolution
Route of AdministrationEXTRACORPOREAL
Marketing Start Date2013-01-10
Marketing CategoryANDA / ANDA
Application NumberBA980728
Labeler NameHaemonetics Corporation
Substance NameANHYDROUS CITRIC ACID; TRISODIUM CITRATE DIHYDRATE; DEXTROSE MONOHYDRATE
Active Ingredient Strength73 mg/mL; mg/mL; mg/mL
Pharm ClassesAcidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 57826-426-04

500 mL in 1 BAG (57826-426-04)
Marketing Start Date2013-01-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 57826-426-04 [57826042604]

Haemonetics Anticoagulant Citrate Dextrose Solution SOLUTION
Marketing CategoryANDA
Application NumberBA980728
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-01-10

Drug Details

Active Ingredients

IngredientStrength
ANHYDROUS CITRIC ACID73 mg/mL

OpenFDA Data

SPL SET ID:2db86c06-bcbc-4b35-83f4-6d7b48985284
Manufacturer
UNII

Pharmacological Class

  • Acidifying Activity [MoA]
  • Calculi Dissolution Agent [EPC]
  • Anti-coagulant [EPC]
  • Decreased Coagulation Factor Activity [PE]
  • Calcium Chelating Activity [MoA]
  • Acidifying Activity [MoA]
  • Calculi Dissolution Agent [EPC]
  • Anti-coagulant [EPC]
  • Decreased Coagulation Factor Activity [PE]
  • Calcium Chelating Activity [MoA]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.